Chief Scientific Officer
Sue Hall serves as Chief Scientific Officer and Head of Research & Development. Dr. Hall has over 30 years’ of international experience in pharmaceutical research and development. Prior to Sebela Pharmaceuticals, Dr. Hall served as EVP, Chief Scientific Officer and Global Head of R&D for Endo Pharmaceuticals with responsibility for the R&D pipeline and life cycle management for the marketed products portfolio of medicines, as well as overall responsibility for the company’s quality assurance activities. Previously, Dr. Hall also served as SVP and Global Head of R&D for Valeant Pharmaceuticals. Dr. Hall also held several R&D leadership positions at GlaxoSmithKline, including clinical pharmacology, project management, medical affairs, and regulatory affairs. Dr. Hall holds a Ph.D. in Pharmacokinetics from the University of Manchester, U.K., and a Bachelor of Science in Pharmacology from University of Leeds, U.K. "